Financial News
Latest News about obesity
Recent news which mentions obesity
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
From CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
From CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
September 09, 2023
From CNBC.com News
Your boarding pass and weight, please: Why airlines are asking passengers to step on the scales
August 27, 2023
Tickers
LIFE
From CNBC.com News
From CNBC.com News
Obesity Drug Wegovy Sales Jump 365% In H1 As Novo Nordisk Reports Solid Results, Raises FY23 Guidance
August 10, 2023
From Benzinga
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
August 09, 2023
From CNBC.com News
Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%
August 08, 2023
From CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
July 27, 2023
From CNBC.com News
From CNBC.com News
Ozempic Alternatives: These Two Drugs Show Promise In Affordability And Effectiveness For Weight Loss
July 24, 2023
From Benzinga
From CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
July 11, 2023
From CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
July 11, 2023
From CNBC.com News
From CNBC.com News
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
May 22, 2023
From CNBC.com News
Weight and Waistline Worries
May 03, 2023
From Stock Gumshoe
Trending billionaire and celebrity GLP-1 weight loss drugs are about to enter more American homes
January 20, 2023
From CNBC.com News
From Benzinga
Short Bits for November
November 30, 2022
From Stock Gumshoe
Banning KFC, McDonald's Near Schools — How Western Australia Plans To Tackle Obesity
November 08, 2022
From Benzinga
2 Biotechs with a possible obesity drug patent??
June 12, 2022
From Stock Gumshoe
From Benzinga
Altimmune's Mid-Stage Pemvidutide Study Cleared By FDA For Obesity
January 31, 2022
Tickers
ALT
From Benzinga
Novo Nordisk Shares Slump As Wegovy Hits US Supply Issues; Deutsche Bank Downgrades
December 20, 2021
Tickers
NVO
From Benzinga
Thanksgiving Left-Overs 2021
November 30, 2021
From Stock Gumshoe
European Authorities Recommend Approval Of Wegovy For Obesity
November 11, 2021
Tickers
NVO
From Benzinga
H.C. Wainwright Sees Buying Opportunity In This Biotech Stock Sell Off
September 28, 2021
Tickers
ALT
From Benzinga
See Why Altimmune Stock Plunged After Obesity Trial Data
September 28, 2021
Tickers
ALT
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
